Gujarat Alkalies & Chemicals Ltd
Gujarat Alkalies & Chemicals Ltd Q1 FY27 Results & Presentation Highlights: Revenue, Margins & Order Book
Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.
Based on Gujarat Alkalies & Chemicals Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Quarterly revenue for Q4 FY26 is INR 1,144 Cr., up from INR 1,004 Cr. Quarterly EBITDA: ₹138 Cr.
From Gujarat Alkalies & Chemicals Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Quarterly revenue for Q4 FY26 is INR 1,144 Cr., up from INR 1,004 Cr. in Q4 FY24 and INR 1,100 Cr. in Q4 FY25, showing a year-on-year (YoY) growth relative to Q4 FY25.
- Sales volume increased 7% annually in FY26 vs. FY25, with a ~10% increase in overall caustic sales driven by exports and domestic demand.
- Overall revenue for FY26 was INR 4,474 Cr., a 7% increase from INR 4,165 Cr. in FY25.
- The presentation targets revenue of over INR 10,000 Cr. by FY31 (5-year outlook).
- Near-term initiatives and capex projects indicate expectations for continued growth, with a ₹5,000+ Cr incremental revenue pipeline identified and ₹600–650 Cr capex planned.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Gujarat Alkalies & Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- CSL revamping & KOH Expansion, Vadodara: Expected commissioning Nov 2028 (Page 18)
- Food Grade Phosphoric Acid plant: Expected commissioning Dec 2028 (Page 18)
- E-Grade Hydrogen Peroxide plant: Expected commissioning Jan 2028 (Page 18)
- 590 Cell Element Replacement at Dahej: Partial delivery received, phase-wise replacement by Nov 2026 (Page 17)
- 200 TPD CS Flaking Unit at Dahej: Engineering complete, major equipment delivery by Aug 2026, completion Dec 2026 (Page 17)
- HCl Synthesis Unit: Procurement by Aug 2026, potential early completion Jan 2027 (Page 17)
- CTS Downstream: Engineering in progress, civil work Oct 2026, completion Mar 2027 (Page 17)
- Biomass/Coal Steam Generation Unit (Dahej & Vadodara): Environmental clearance for Dahej received, boiler order by Aug 2026, completion Jun 2028 (Page 17)
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Gujarat Alkalies & Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Gujarat Alkalies & Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.0K Cr, net loss ₹20 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Gujarat Alkalies & Chemicals Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key investor presentation takeaways from Fine
- Chemfab Alkalis Ltd (Q1 FY27)
Consolidated Q1FY27 Revenue from Operations:** ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). Key investor presentation takeaways from Chemfab Alk
- Amines & Plasticizers Ltd (Q1 FY27)
Q1FY27 Revenue from Operations: ₹150.53 Crores, a 7% year-on-year increase from Q1FY26 (₹140.29 Crores). Key investor presentation takeaways from Amines & Plast
- Sudarshan Pharma Industries Ltd (Q1 FY27)
Revenue from Operations for June 2026 quarter: ₹174.41 Cr (Page 39) . Key investor presentation takeaways from Sudarshan Pharma Industries Ltd's Q1 FY27 investo
Frequently Asked Questions
What were Gujarat Alkalies & Chemicals Ltd Q1 FY27 results?
Quarterly revenue for Q4 FY26 is INR 1,144 Cr., up from INR 1,004 Cr. Quarterly EBITDA: ₹138 Cr.
What is Gujarat Alkalies & Chemicals Ltd share price analysis?
Gujarat Alkalies & Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 70.7 with a market cap of ₹4,691 Cr. Investors should review the full earnings analysis for detailed insights.
Is Gujarat Alkalies & Chemicals Ltd planning capital expenditure?
CSL revamping & KOH Expansion, Vadodara: Expected commissioning Nov 2028 (Page 18) - Food Grade Phosphoric Acid plant: Expected commissioning Dec 2028 (Page 18) - E-Grade Hydrogen Peroxide plant:
Keep Gujarat Alkalies & Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.